Laboratorios Farmaceuticos Rovi SA (id:4678 ROVI)
61.70 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/24/2024 5:27:28 PM)
Exchange open, closes in 2 minutes
About Laboratorios Farmaceuticos Rovi SA
Market Capitalization 3.14B
Laboratorios Farmaceuticos Rovi, S.A. engages in the research, development, manufacture, and marketing of pharmaceutical products in Spain and internationally. The company provides products for cardiology, osteoarticular/women's health, anesthesia /pain, diagnostic imaging contrast agents, central nervous system, urology, endocrinology, respiratory, and primary healthcare areas. Its principal products include Ameride, Bertanel, Bluxam, Enoxaparin Rovi, Calcium Vitamine D3 Rovi, Exxiv, Prinvil, Rhodogil, Glufan, Hibor, Hirobriz Breezhaler, Neparvis, Medicebran, Medikinet, Mysimba, Orvatez, Tryptizol, Ulunar Breezhaler, and Volutsa; and hospital products, such as Iomeron and Iopamiro, Multihance and Y Prohance, Sonovue, Empowercta+, Empowermr, and CT Express, Fibrilin, and Sodium Heparin Rovi. It also provides contract-manufacturing services to other companies for a range of pharmaceutical forms, including prefilled syringes, vials, suppositories, tablets, and sachets. Laboratorios Farmaceuticos Rovi, S.A. was incorporated in 1946 and is headquartered in Madrid, Spain. Laboratorios Farmaceúticos Rovi, S.A. is a subsidiary of Norbel Inversiones, S.L.
| Headquarters (address) |
Calle JosE Isbert, 2 Madrid 28223 Spain |
| Phone | 34 91 021 30 00 |
| Website | https://www.rovi.es |
| Employees | 2K |
| Sector | Healthcare |
| Industry | Biotechnology |
| Ticker | ROVI |
| Exchange | Madrid Stock Exchange |
| Currency | EUR |
| 52 week range | 59.05 - 94.80 |
| Market Capitalization | 3.14B |
| Dividend yield forward | 7.19 % |
| Dividend yield forward Spain (ID:221, base:120) | 11.71 % |
| P/E trailing | 19.31 |
| P/E forward | 22.66 |
| Price/Sale | 3.93 |
| Price/Book | 5.97 |
| Beta | 3.00 |
| EPS | 3.18 |
| EPS Spain (ID:221, base:143) | 3.00 |
Dividend growth streak
Laboratorios Farmaceuticos Rovi SA has raised their dividend 4.00 years in a row. This is below the 4.499729 year average in the 'Biotechnology' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Laboratorios Farmaceuticos Rovi SA has raised their dividend 7.19 years in a row. This is below the 42121.883300 year average in the 'Biotechnology' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Laboratorios Farmaceuticos Rovi SA has raised their dividend 94.77 years in a row. This is above the 23.957000 year average in the 'Biotechnology' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Laboratorios Farmaceuticos Rovi SA has raised their dividend 60.71 years in a row. This is above the 12.560500 year average in the 'Biotechnology' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Laboratorios Farmaceuticos Rovi SA has raised their dividend 25.21 years in a row. This is above the 10.207200 year average in the 'Biotechnology' industry
Payout Ratio
Payout Ratio: Laboratorios Farmaceuticos Rovi SA has raised their dividend 34.74 years in a row. This is below the 148.467900 year average in the 'Biotechnology' industry
Dividend growth streak
Laboratorios Farmaceuticos Rovi SA has raised their dividend 4.00 years in a row. This is below the 4.499729 year average in the 'Biotechnology' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Laboratorios Farmaceuticos Rovi SA has raised their dividend 7.19 years in a row. This is below the 42121.883300 year average in the 'Biotechnology' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Laboratorios Farmaceuticos Rovi SA has raised their dividend 94.77 years in a row. This is above the 23.957000 year average in the 'Biotechnology' industry
Compound Average Growth Rate 5 Years
Compound Average Growth Rate 5 Years: Laboratorios Farmaceuticos Rovi SA has raised their dividend 60.71 years in a row. This is above the 12.560500 year average in the 'Biotechnology' industry
Compound Average Growth Rate 10 Years
Compound Average Growth Rate 10 Years: Laboratorios Farmaceuticos Rovi SA has raised their dividend 25.21 years in a row. This is above the 10.207200 year average in the 'Biotechnology' industry
Payout Ratio
Payout Ratio: Laboratorios Farmaceuticos Rovi SA has raised their dividend 34.74 years in a row. This is below the 148.467900 year average in the 'Biotechnology' industry